This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Axon Tops Q2 Earnings & Revenue Estimates, Raises 2025 Guidance
by Zacks Equity Research
AXON crushes Q2 expectations with 74% EPS growth and raises its 2025 outlook as TASER, body cam and software demand soars.
Axon (AXON) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Axon (AXON) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Axon Enterprise (AXON) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Axon (AXON) delivered earnings and revenue surprises of +37.66% and +3.98%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Sonos to Announce Q3 Earnings: Here's What You Should Know
by Zacks Equity Research
SONO braces for y/y Q3 revenue decline despite sequential growth, as tariff costs and weak consumer demand weigh on results.
Should Axon Enterprise Stock be in Your Portfolio Pre-Q2 Earnings?
by Avisekh Bhattacharjee
AXON eyes another earnings beat as TASER, body cameras and cloud services drive strong Q2 growth across key segments.
Will Solid Segmental Sales Boost TransDigm's Q3 Earnings?
by Zacks Equity Research
TDG's Q3 results are likely to get a lift from strong commercial air travel demand and rising defense-related segment sales.
BWX Technologies to Report Q2 Results: What's in Store for the Stock?
by Zacks Equity Research
BWXT's Q2 sales are expected to rise 5.1%, but earnings are likely to dip as margins face pressure from rising costs.
Axon (AXON) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
by Zacks Equity Research
Get a deeper insight into the potential performance of Axon (AXON) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Axon Enterprise (AXON) Sees a More Significant Dip Than Broader Market: Some Facts to Know
by Zacks Equity Research
Axon Enterprise (AXON) closed at $728.74 in the latest trading session, marking a -1.03% move from the prior day.
FTAI Aviation (FTAI) Tops Q2 Earnings Estimates
by Zacks Equity Research
FTAI Aviation (FTAI) delivered earnings and revenue surprises of +18.05% and -10.40%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TransDigm Group (TDG) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
TransDigm (TDG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Axon's AI-Driven Platform Continue to Enhance Community Safety?
by Zacks Equity Research
AXON's AI-powered tools like Draft One and Redaction Assistant are fueling surging growth in public safety tech.
Axon Enterprise (AXON) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Axon (AXON) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Poor Segmental Sales Performance Impact HII's Q2 Earnings?
by Zacks Equity Research
HII's Q2 earnings face pressure from revenue declines across all segments and margin weakness at Ingalls.
Wall Street Analysts See Axon (AXON) as a Buy: Should You Invest?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Axon (AXON). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Here is What to Know Beyond Why Axon Enterprise, Inc (AXON) is a Trending Stock
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Axon (AXON). This makes it worthwhile to examine what the stock has in store.
How to Boost Your Portfolio with Top Aerospace Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Axon Eyes Expansion in Drone Equipment Space: Can It Deliver Growth?
by Zacks Equity Research
AXON's drone push gains traction with Skydio, Dedrone deals and rising public safety demand fueling future growth.
Woodward Acquires Safran's North American Electromechanical Unit
by Zacks Equity Research
WWD completes Safran deal, gaining A350 HSTA systems and key assets to deepen its aerospace control offerings.
Axon Enterprise (AXON) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
In the latest trading session, Axon Enterprise (AXON) closed at $756.09, marking a +1.37% move from the previous day.
Axon vs. Teledyne: Which Defense & Security Stock has Better Prospects?
by Avisekh Bhattacharjee
AXON outpaces TDY with 25.6% stock gain and stronger sales growth, fueled by soaring demand for TASERs and digital tools.
AXON's Software & Services Growth Picks Up: More Upside to Come?
by Avisekh Bhattacharjee
Axon Enterprise's Software & Services revenues surge 39% in Q1 2025, fueled by rising ARR and premium plan adoption momentum.
Axon Enterprise, Inc (AXON) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Axon (AXON) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Axon Enterprise (AXON) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
In the latest trading session, Axon Enterprise (AXON) closed at $805.86, marking a +1.98% move from the previous day.
Strength in Connected Devices Unit Drives Axon: Can the Momentum Sustain?
by Zacks Equity Research
AXON's Connected Devices segment surges 26.1% in Q1 2025, fueled by strong TASER 10 and Axon Body 4 demand.